AI assistant
Sending…
UPEXI, INC. — Director's Dealing 2025
Nov 19, 2025
33031_dirs_2025-11-18_251fed85-eb13-4411-82e9-7388ad532523.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UPEXI, INC. (UPXI)
CIK: 0001775194
Period of Report: 2025-11-17-05:00
Reporting Person: Salkind Gene (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-17-05:00 | Common Stock | P | 100000 | $2.65 | Acquired | 569470 | Direct |
| 2025-11-17-05:00 | Common Stock | P | 100000 | $2.81 | Acquired | 168750 | Indirect |
Footnotes
F1: 100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind.
More from UPEXI, INC.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 11
Interim / Quarterly Report
2026
Feb 10
Regulatory Filings
2026
Feb 10
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4